title: Cholesterol Efflux Capacity as a Therapeutic Target: Rationale and Clinical Implications.
authors.affiliation: Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.
authors.forename: Anand
authors.initials: A
authors.lastname: Rohatgi
authors.affiliation: Department of Internal Medicine, University of Texas Southwestern and Veteran Affairs Medical Center, Dallas, Texas. Electronic address: Scott.grundy@utsouthwestern.edu.
authors.forename: Scott M
authors.initials: SM
authors.lastname: Grundy
mesh_terms: D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000627:therapeutic use*; D002784:Cholesterol / Q000097:blood*; D050171:Dyslipidemias / Q000188:drug therapy*; D005260:Female; D053442:High-Density Lipoproteins, Pre-beta / Q000097:blood*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D008297:Male
chemical_list: D000924:Anticholesteremic Agents; D053442:High-Density Lipoproteins, Pre-beta; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D001569:Benzodiazepines; D002784:Cholesterol
keywords: ABAC1; CETP; HDL functionality; cholesterol efflux